TRT(SH:600085) Guan Cha Zhe Wang·2025-12-15 13:22Core Viewpoint - Beijing Tongrentang has taken immediate action against a product labeled as "99% high-purity Antarctic krill oil," which is suspected of false ingredient labeling, by halting its distribution and initiating legal proceedings against the involved company [1][4]. Group 1: Company Actions - The company has ordered its subsidiary, Sichuan Tongrentang Health Pharmaceutical Co., Ltd., to stop the distribution of the questionable product and is conducting a full traceability check [1]. - Legal action has been initiated against the involved parties to protect consumer rights and the company's brand image [1]. Group 2: Product Details - A recent consumer protection investigation revealed that the krill oil product, which claimed to contain a high phospholipid content, was found to have zero phospholipid content in actual testing [4][5]. - The product was marketed with claims of high content and imported raw materials, but the actual composition raises significant concerns about its authenticity [4][6]. Group 3: Industry Context - Antarctic krill oil is known for its phospholipid content, which is essential for its emulsifying properties and absorption; the absence of phospholipids in the product contradicts its fundamental definition [6]. - The product in question is considered a "private label" item of Beijing Tongrentang, as it is produced by Anhui Habao Pharmaceutical Co., Ltd. and distributed by its subsidiary [6].